Fluorescence, DNA Interaction and Cytotoxicity Studies of 4,5-Dihydro-1H-Pyrazol-1-Yl Moiety Based Os(IV) Compounds: Synthesis, Characterization and Biological Evaluation

被引:3
作者
Pursuwani, Bharat H. [1 ]
Bhatt, Bhupesh S. [1 ]
Vaidya, Foram U. [2 ]
Pathak, Chandramani [2 ]
Patel, Mohan N. [1 ]
机构
[1] Sardar Patel Univ, Dept Chem, Vallabh Vidyanagar 388120, Gujarat, India
[2] Indian Inst Adv Res, Cell Biol Lab, Gandhinagar 382421, Gujarat, India
关键词
Binding; Absorption titration; Molecular docking; HCT-116; MOLECULAR DOCKING; ANTIMICROBIAL ACTIVITY; DNA/PROTEIN BINDING; ANTICANCER ACTIVITY; PD(II) COMPLEXES; QUINOLINE; OSMIUM(III); RUTHENIUM(II); ANTIOXIDANT; TOXICITY;
D O I
10.1007/s10895-020-02657-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Osmium(IV) pyrazole compounds and ligands were synthesized and well characterised. Ligands were characterized by heteronuclear NMR spectroscopy (H-1 & C-13), elemental analysis, IR spectroscopy and liquid crystal mass spectroscopy. Os(IV) complexes were characterized by ESI-MS, ICP-OES, IR spectroscopy, conductance measurements, magnetic measurements and electronic spectroscopy. Binding of compounds with HS-DNA were evaluated using viscosity measurements, absorption titration, fluorescence quenching, and molecular docking, which show effective intercalation mode exhibited by compounds. Binding constant of Os(IV) complexes are found to be 8.1 to 9.2 x 10(4) M-1. Bacteriostatic and cytotoxic activities were carried out to evaluate MIC, LC50, and IC50. The compounds have been undergone bacteriostatic screening using three sets of Gram(+ve) and two sets of Gram(-ve) bacteria. MIC of complexes are found to be 72.5-100 mu M, whereas that of ligands fall at about 122.5-150 mu M.. LC50 count of ligands fall in the range of 16.22-17.28 mu g/mL whereas that of complexes of Os(IV) fall in the range of 4.87-5.87 mu g/mL. IC50 of osmium compounds were evaluated using HCT-116 cell line. All the Os(IV) compounds show moderate IC50.
引用
收藏
页码:349 / 362
页数:14
相关论文
共 50 条
  • [31] Microwave-assisted synthesis and antimicrobial evaluation of 6-[3-aryl-1-phenyl-4′,5′-dihydro[4,5′-bi-1H-pyrazol]-3′-yl]-2H-chromen-5-ols
    Ashok, Dongamanti
    Kavitha, Rangu
    Gundu, Srinivas
    Sarasija, Madderla
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2019, 84 (03) : 237 - 244
  • [32] Synthesis and the interaction of 2-(1H-pyrazol-4-y1)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors
    Liu, Jiachun
    Chen, Mei
    Wang, Yanli
    Zhao, Xiaoyin
    Wang, Sijia
    Wu, Yanling
    Zhang, Wen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 133 : 36 - 49
  • [33] Green synthesis, antimycobacterial evaluation and molecular docking studies of novel 2,3-dihydro-1H-pyrazol-4-ylnaphthalene-1,4-diones
    Hiwarale, Dipak P.
    Chandane, Wilson B.
    Deshmukh, Sandip M.
    Arde, Satyanarayan M.
    Sonawane, Vikas D.
    Kukade, Mahesh G.
    Naik, Nitin M.
    Sonawane, Kailas D.
    Rashinkar, Gajanan S.
    Sonkamble, Shivanand G.
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1286
  • [34] Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors
    Zhao, Meng-Yue
    Yin, Yong
    Yu, Xiao-Wei
    Sangani, Chetan B.
    Wang, Shu-Fu
    Lu, Ai-Min
    Yang, Li-Fang
    Lv, Peng-Cheng
    Jiang, Ming-Guo
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (01) : 46 - 54
  • [35] Glycerol Mediated Synthesis, Biological Evaluation, and Molecular Docking Study of 4-(1H-pyrazol-4-yl)-polyhydroquinolines as Potent Antitubercular Agents
    Jamale, Dattatraya K.
    Undare, Santosh S.
    Valekar, Navanath J.
    Sarkate, Aniket P.
    Kolekar, Govind B.
    Anbhule, Prashant V.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (02) : 608 - 618
  • [36] Fe3O4 Nanoparticles Catalyzed Tandem Synthesis of Fluorescent 3-(4,5-diaryl-1H-imidazol-2-yl) quinoline-2-amines: Solvatochromic, DFT and Biological Studies
    Bheemayya, Lokesh
    Kamble, Ravindra R.
    Sannaikar, Madivalagouda S.
    Inamdar, Sanjeev R.
    Metre, Tukaram V.
    Kodasi, Barnabas
    Hoolageri, Swati R.
    Nadoni, Vishwa B.
    Joshi, Shrinivas D.
    Kumar, S. K. Praveen
    Dalbanjan, Nagarjuna Prakash
    Pasha, K. M. Mussuvir
    Keri, Rangappa S.
    CHEMISTRYSELECT, 2023, 8 (40):
  • [37] Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity
    Cai, Zheng-Yu
    Yang, Yang
    Liu, Xin-Hua
    Qi, Xing-Bao
    LETTERS IN DRUG DESIGN & DISCOVERY, 2010, 7 (09) : 640 - 643
  • [38] SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL STUDIES OF N'-((5-CHLORO-3-METHYL-1-PHENYL-1H-PYRAZOL-4YL) METHYLENE SCHIFF'S BASE LIGANDS AND THEIR TRANSITION METAL COMPLEXES
    Bhangale, Pallavi R.
    Chaudhari, Rakesh P.
    Patil, Machindra B.
    HETEROCYCLIC LETTERS, 2024, 14 (03): : 569 - 582
  • [39] Synthesis, crystal structure, Hirshfeld surface, DFT and docking studies of 4-[(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)(phenyl)methyl]-5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
    Rajamanickam, Ramachandran
    Sivakolunthu, Senthan
    Sampathkumar, Jayanthi
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1252
  • [40] Synthesis, characterization and biological evaluation of 7-substituted-4-((1-aryl-1H-1,2,3-triazol-4-yl) methyl)-2H-benzo[b][1,4]oxazin-3(4H)-ones as anticancer agents
    Nagavelli, Vasudeva Reddy
    Nukala, Satheesh Kumar
    Narsimha, Sirassu
    Battula, Kumara Swamy
    Tangeda, Savitha Jyostna
    Reddy, Yellu Narasimha
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (09) : 1781 - 1793